General
1 min read
Mecara CEO Hiromi Kawamata has been named to the EY Entrepreneurial Winning Women Asia-Pacific Class...
The AMW Read
Provides an incremental update on a specialized player in the AI-driven healthcare/diagnostics sub-segment, noting their regulatory pursuit and government grant.
NoveltySignificance
Healthcare & Bio · Player Map
Mecara CEO Hiromi Kawamata has been named to the EY Entrepreneurial Winning Women Asia-Pacific Class of 2026, recognizing her work in AI-driven digital pupillometry that measures autonomic nervous system function in just 7 seconds. The Tokyo-based startup, founded in 2019, has secured a 700 million yen government medical innovation grant and is pursuing PMDA regulatory approval for its AiLive device, which serves hospitals and corporations across Japan. Mecara plans to expand across Asia-Pacific and enter the US market within 3-5 years, transitioning from a hardware device model to a comprehensive SaaS and data analytics platform for preventive health.